Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients
Top Cited Papers
- 18 May 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 190 (2), E64-E67
- https://doi.org/10.1111/bjh.16852
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patientsJournal of Medical Virology, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemicBlood, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Provision of cancer care during the COVID-19 pandemicNature Reviews Clinical Oncology, 2020
- Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysisJournal of Medical Virology, 2020
- Acute leukemia in the time of COVID-19Leukemia Research, 2020
- Care of haematology patients in a COVID‐19 epidemicBritish Journal of Haematology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020